Safety and Efficacy of Co-Careldopa as an Add-On Therapy to Occupational and Physical Therapy in Patients After Stroke (DARS): A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(19)30147-4
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

Exploratory Randomized Double-Blind Placebo-Controlled Trial of Botulinum Therapy on Grasp Release After Stroke (PrOMBiS)

Neurorehabilitation and Neural Repair
NeurologyRehabilitation
2019English

Management of Asthma in School Age Children on Therapy (MASCOT): A Randomised, Double-Blind, Placebo-Controlled, Parallel Study of Efficacy and Safety

Health Technology Assessment
MedicineHealth Policy
2013English

Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial

Gut
Gastroenterology
2000English

Feasibility Study of a Single-Blind Randomised Controlled Trial of an Occupational Therapy Intervention

Scandinavian Journal of Occupational Therapy
EnvironmentalPublic HealthOccupational Health
2015English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Efficacy of Sodium Butyrate Adjunct Therapy in Shigellosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BMC Infectious Diseases
Infectious Diseases
2012English

Efficacy and Safety of Methotrexate Add-On Therapy Versus Placebo for Patients With Chronic Spontaneous Urticaria Resistant to H1-Antihistamines: A Randomized, Controlled Trial

Journal of the American Academy of Dermatology
Dermatology
2020English

Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

ADD-ASPIRIN: A Phase III, Double-Blind, Placebo Controlled, Randomised Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non-Metastatic Solid Tumours

Contemporary Clinical Trials
MedicinePharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy